"Experts Caution Against $2.50 Pill for Autism Symptoms Amid Fast-Track Approval"

Experts warn against the fast-track approval of leucovorin, a $2.50 pill, for symptoms associated with autism spectrum disorders, stressing the need for caution in treatment.

• The American Academy of Pediatrics announced that leucovorin, also known as Folinic acid, is not recommended for routine use in children with autism spectrum disorders.
• Leucovorin, derived from folate, has been used since the 1950s primarily for cancer patients, raising concerns about its efficacy in treating autism spectrum symptoms.
• The Food and Drug Administration is currently fast-tracking the approval process for leucovorin, which has sparked debate among doctors about its potential risks and benefits.